BEAM
#1695
Beam Therapeutics Inc. - Common Stock
30.4 8 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.96%
Changement Mensuel
+16.38%
Evolution sur 6 mois
+11.28%
Changement Annuel
+80.68%
Clôture Précédente
30.1 9
Open
30.4 8
Low
30.4 8
High
30.4 8
Volume
133
Financials
- Market Capitalization 3.15 B
- Employee 540
- Founded 2017
- CEO John Evans
- Website www.beamtx.com
- Headquarter Delaware, United States
- FIGI BBG00KXC8646
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-34.22
ratio cours/chiffre d'affaires
19.62
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1688 |  IRON Disc Medicine, Inc. - Common Stock | 82.55 USD | -0.15% | +3.84% | +10.86% | +37.93% | 3.17 B USD | ||
| 1694 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.92 USD | +1.80% | +0.28% | +22.40% | +8.87% | 3.16 B USD | ||
| 1701 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.87 USD | -1.07% | -2.43% | -11.84% | +60.14% | 3.13 B USD | ||
| 1716 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 15.21 USD | +10.78% | +12.09% | +51.49% | +680.00% | 3.07 B USD |